CPT® Code 95125

1. Indications

Allergen immunotherapy is indicated for patients experiencing allergic reactions to specific allergens. The following conditions and symptoms warrant the use of this treatment:

• Seasonal Allergies - Patients suffering from allergies related to pollen from grasses, weeds, and trees.
• Indoor Allergies - Individuals with allergies to common indoor allergens such as dust mites, pet dander, and molds.

2. Procedure

The procedure for allergen immunotherapy involves several key steps that ensure the safe and effective administration of allergenic extracts. The following outlines the procedural steps:

• Step 1: Allergy Testing - Prior to initiating immunotherapy, patients undergo allergy testing to identify specific allergens that trigger their allergic reactions. This testing is crucial for developing a targeted treatment plan.
• Step 2: Development of Immunotherapy Schedule - Based on the results of the allergy testing, a personalized immunotherapy schedule is created. This schedule includes two phases: the build-up phase and the maintenance phase.
• Step 3: Build-Up Phase - During this initial phase, patients receive small doses of the allergenic extract(s) through injections, typically administered in the upper arm. The frequency of these injections can range from one to three times per week, and this phase usually lasts for three to six months. The doses are gradually increased to build tolerance to the allergens.
• Step 4: Maintenance Phase - After the build-up phase, patients transition to the maintenance phase, where they receive monthly injections of the allergenic extract for a duration of three to five years. This phase aims to maintain the patient's tolerance to the allergens and reduce allergy symptoms over time.
• Step 5: Provision of Allergenic Extract - The allergenic extract used in the immunotherapy is prepared and provided by the physician or other qualified healthcare professional, ensuring that the treatment is tailored to the patient's specific allergic profile.

3. Post-Procedure

After the administration of allergen immunotherapy injections, patients are typically monitored for a short period to observe for any immediate adverse reactions. It is important for patients to report any unusual symptoms or side effects to their healthcare provider. Following the injections, patients may continue with their regular activities, but they should adhere to the prescribed schedule for subsequent injections. Long-term follow-up is essential to assess the effectiveness of the therapy and make any necessary adjustments to the treatment plan. Patients are encouraged to maintain open communication with their healthcare provider regarding their allergy symptoms and overall response to the immunotherapy.